Sat.Jun 01, 2024 - Fri.Jun 07, 2024

article thumbnail

Pharmacy Technician Immunizers Can Provide The Much Needed Shot In The Arm For Community Pharmacies

Pharmacy Times

The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members

article thumbnail

GLP-1s May Lower Risk of Acute Pancreatitis in Patients with T2D, Obesity

Drug Topics

Research presented at ENDO 2024 found that glucagon-like peptide-1 receptor agonists had a lower acute pancreatitis recurrence risk than SGLT2i, DPP4i, and no medication.

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

‘Concern is real’ about long Covid’s impact on Americans and disability claims, report says

STAT

The Covid pandemic has been called a “mass-disabling event” since early on — the kind of once-in-a-generation public health crisis that could shape millions of people’s lives forever. But while more people self-identified as disabled since the pandemic began, applications for disability benefits have stayed level, according to data from the Social Security Administration.

145
145
article thumbnail

After 33 years, Geron finally crosses FDA finish line with blood cancer med Rytelo

Fierce Pharma

Once hailed as an anti-aging magic bullet, telomerase has failed to live up to the hype as it was profiled in a | The FDA has approved Geron Corporation's Rytelo (imetelstat) to treat a group of bone marrow disorders called myelodysplastic syndrome (MDS). The approval is the first for the 33-year-old California biotech.

FDA 134
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Researchers Find Shared Multiomic Molecular Dysregulations in Brains With PTSD and MDD

Pharmacy Times

The investigators are optimistic that the data can establish stress-related pathways while revealing potential therapeutic options for patients with major depressive disorder and post-traumatic stress disorder.

149
149
article thumbnail

National Nurses United pushes back against deployment of ‘unproven’ AI in healthcare

Fierce Healthcare

The nation’s largest nurses union is demanding that artificial intelligence tools used in healthcare be proven safe and equitable before deployment. | A union organization for nurses nationwide says the deployment of AI in healthcare will push nurses out of patient rooms and compromise patient safety. A new AI Bill of Rights lays out nurse and patient protections, which are not currently being met.

137
137

More Trending

article thumbnail

Pharmacogenomics and IVDR: Overcoming transition challenges

pharmaphorum

Understanding the challenges and opportunities in transitioning to IVDR for pharmacogenomics can be complex. Learn more about how to overcome these challenges effectively.

124
124
article thumbnail

Cost Remains Significant Barrier to Respiratory Care for Patients

Pharmacy Times

By improving health insurance coverage and cost of inhalers, such as out-of-pocket caps, access to care can be increased. Some companies are aiming to improve access by implementing price caps.

article thumbnail

Industry Voices—Walmart's exit from health centers reflects broader challenges in primary care

Fierce Healthcare

Walmart announced that it is closing all 51 of its health centers and virtual care ope | The hope that retailers were poised to offer a scaled-up solution has yielded to a more realistic view that, at best, it will be a long journey.

128
128
article thumbnail

Opinion: 100,000 models show that not much was learned about stopping the Covid-19 pandemic

STAT

In the midst of the Covid-19 pandemic, scientists and public health institutions made bold claims about the effectiveness of various policy responses such as closing schools and banning public gatherings. These claims shaped government responses and had enormous effects on the lives of billions of people around the world. Are those claims supported by data?

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Bristol Myers puts more than 860 jobs on chopping block in NJ as $1.5B savings campaign rolls ahead

Fierce Pharma

The scope of Bristol Myers Squibb’s $1.5 billion savings drive is beginning to come into focus. | Starting this month, BMS will begin the process of laying off around 863 employees in Lawrenceville, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) alert from the state. The move forms part of BMS’ campaign to shave off $1.5 billion in costs by the end of 2025, a company spokesperson said over email.

119
119
article thumbnail

Understanding the Connection Between Genetic Risk and Brain Cell Activity in Autism Spectrum Disorder

Pharmacy Times

Over the course of 15 years, epigenetic and transcriptional analysis of postmortem brain samples have revealed underlying molecular differences.

156
156
article thumbnail

Appeals court upholds ruling barring former Express Scripts chief from joining CVS

Fierce Healthcare

A federal appeals court has upheld an injunction preventing the former head of Express Scripts from taking an executive role at CVS Health. | A federal appeals court has upheld an injunction preventing the former head of Express Scripts from taking an executive role at CVS Health.

125
125
article thumbnail

These are the bird flu questions that influenza and animal scientists desperately want answered

STAT

Ten weeks after government scientists discovered that H5N1 bird flu was sickening dairy cattle in the United States, many of the mysteries surrounding what is happening on affected farms remain just that. Widespread reluctance on the part of farmers to allow scientists — government or otherwise — onto their premises to study spread of the virus among infected cows has created a frustrating lack of understanding of the dynamics of this outbreak.

145
145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation

Fierce Pharma

A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. AstraZeneca’s Tagrisso just delivered an 84% improvement. | A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. AstraZeneca’s Tagrisso just delivered an 84% and earned a standing ovation at ASCO 2024.

121
121
article thumbnail

Study: Tezepelumab Reduces Annual Rates of Exacerbations Related to COPD

Pharmacy Times

For patients with a blood eosinophil count of 150 cells/µL or greater, tezepelumab had a significant reduction of approximately 37% in the rate of moderate or severe exacerbations.

131
131
article thumbnail

In-person, virtual support groups now available to Navajo veterans

Fierce Healthcare

Navajo veterans can now access in-person and virtual peer support groups thanks to a partnership between Televeda and the Navajo Nation Veterans Administration. | The support groups take the form of talking circles, deeply rooted in the traditional practices of Indigenous people. Televeda is also offering other virtual talking circles for women and LGBTQ+ individuals.

122
122
article thumbnail

A new discovery about carbon dioxide is challenging decades-old ventilation doctrine

STAT

Carbon dioxide monitors have been around for decades. But in 2020, they became, almost overnight, a hot commodity. All of a sudden, people wanted them to help assess the safety of indoor spaces — to gauge the likelihood of breathing in coronavirus-laced particles that until very recently had been in someone else’s lungs. No sensor can monitor how many infectious aerosols are swirling around us in real time.

145
145
article thumbnail

Key takeaways from ViVE: AI, security concerns, and industry transactions take centre stage

pharmaphorum

ViVE conference highlights the key takeaways on artificial intelligence, cybersecurity concerns, and industry transactions. Stay updated on the latest trends and partnerships shaping these fields.

119
119
article thumbnail

Patients With SCD Who Experience Longer Delays Transitioning Between Care More Likely to Be Hospitalized

Pharmacy Times

Patients with sickle cell disease with more than a 6-month delay transitioning from pediatric to adult care were about twice as likely to be hospitalized.

Hospitals 132
article thumbnail

Blue KC exiting Medicare Advantage market by 2025 due to 'regulatory demands'

Fierce Healthcare

Blue Cross and Blue Shield of Kansas City is leaving the Medicare Advantage (MA) market at the end of 2024, the insurer announced recently. | Blue Cross and Blue Shield of Kansas City is opting out of the Medicare Advantage market. The health plan said its relatively low membership and burdensome regulatory factors meant the company no longer view the market as financially viable.

Insurance 123
article thumbnail

Federal officials and physician groups express outrage over revelations of recent coercive sterilizations

STAT

Federal officials, medical organizations, and reproductive health advocacy groups have expressed outrage in response to STAT’s recent investigation revealing that women with sickle cell disease have felt pressured into sterilizations as recently as 2017 and 2022. Some said they knew of other contemporary instances of tubal ligations with questionable consent — in people with severe disabilities, for instance, or situations in which patients didn’t understand that the procedu

141
141
article thumbnail

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has retu | A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.

119
119
article thumbnail

Association Found Between OTC Male Enhancement Supplementation and Liver Injuries

Pharmacy Times

Promises of sexual improvement may ensnare unsuspecting patients with potentially dangerous adverse effects from untested OTC remedies.

139
139
article thumbnail

Burdensome step therapy requirements could delay care for cancer patients: analysis

Fierce Healthcare

Restrictive health plan policies are increasingly relying on step therapy for cancer drugs, recent analysis from consulting firm Avalere shows. | Step therapy is embedded within prior auth requirements by health plans, potentially delaying critical access to care for cancer patients. In rare circumstances, patients must go through triple or quadruple step therapy.

118
118
article thumbnail

Smoke exposure from California’s wildfires linked to 52,000 early deaths, study says

STAT

When large swaths of the East Coast were shrouded in wildfire smoke last summer, scientists in California grimly joked that maybe, finally, power brokers in New York and Washington, D.C. would be spurred to act on the burning issue that has long plagued the West Coast. Despite wildfire seasons that regularly burn hundreds of thousands of acres in California alone each year, researchers know relatively little about the long-term effects of chronic wildfire smoke on the body , and funding to reduc

138
138
article thumbnail

ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer

Fierce Pharma

After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that the antibody-drug conjugate can reach tumors with an even lower express | After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that the antibody-drug conjugate can reach tumors with an even lower expression of the protein biomarker.

119
119
article thumbnail

FDA Advisory Panel Rejects MDMA-Assisted Therapy for PTSD

Pharmacy Times

The panelists expressed concerns about clinical trial data and concluded that the benefits do not outweigh the risks, but the FDA does not have to follow their recommendation.

FDA 120
article thumbnail

Oscar Health growth ambitions: Doubled footprint, planned ICHRA products launch and more

Fierce Healthcare

Sensing an opportunity in the individual market, Oscar Health believes it is poised to expand and increase its market share, the company revealed ahead of its annual investor day June 7. | Oscar Health execs outlined the company's three-year vision during June 7's investor day. The insurer plans to make more headway in the ACA market and ICHRA through robust expansion and strong financial performance.

Insurance 117
article thumbnail

STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD

STAT

Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for MDMA-assisted psychotherapy to treat post-traumatic stress disorder. The discussion will start at 8:30 a.m. ET and run until about 5:30 p.m. ( here’s an agenda ). We published an in-depth story on Friday about what to expect today , but here are the basics: MDMA is the first Schedule I psychedelic to be considered by

FDA 141
article thumbnail

First rare disease therapies chosen for FDA START programme

pharmaphorum

An initiative set up by the FDA to accelerate the development of therapies for rare disease in the same way that Operation Warp Speed delivered COVID-19 vaccine has chosen its first pilot programme candidates.

FDA 115
article thumbnail

Can prednisone make you tired?

The Checkup by Singlecare

Prednisone is a corticosteroid medication that helps reduce inflammation. This versatile prescription drug is FDA-approved to treat autoimmune and inflammatory conditions such as arthritis, lupus, psoriasis, ulcerative colitis, multiple sclerosis, and endocrine disorders. It can also treat severe allergic reactions. Like any medication, prednisone may cause side effects for some people.

Dosage 111
article thumbnail

Kaufman Hall: Hospital margins, outpatient revenue grew in April

Fierce Healthcare

Amid a relatively strong first quarter for the sector, hospitals’ financial performance improved from March to April, per a new Kaufman Hall report. | Margins, outpatient revenue and operating room minutes all increased in April, the report found.

Hospitals 120
article thumbnail

STAT+: Student group that ranked med schools over industry conflicts votes to accept pharma funding

STAT

An organization devoted to educating future doctors about conflicts of interest will now accept industry funding due to financial stress, prompting outrage from former members who argue the decision will undermine its mission. In a little-noticed move, the American Medical Student Association board recently approved an emergency resolution to accept money from drug and device makers, as well as health insurers, so long as funding does not exceed 25% of its operating budget.

Insurance 138